Inquire Before Buying
Speak to an Analyst 
Request Brochure 
Request CustomizationIMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
Read More
Vaccine Market Report by Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, and Others), Patient Type (Pediatric, Adult), Indication (Bacterial Diseases, Viral Diseases), Route of Administration (Intramuscular and Subcutaneous Administration, Oral Administration, and Others), Product Type (Multivalent Vaccine, Monovalent Vaccine), Treatment Type (Preventive Vaccine, Therapeutic Vaccine), End User (Hospitals, Clinics, Vaccination Centers, Academic and Research Institutes, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Institutional Sales, and Others), and Region 2024-2032
Report Format: PDF+Excel | Report ID: SR112024A2374
Buy Now
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
4.2.1 Regulatory Landscape
4.2.1.1 United States
4.2.1.2 Canada
4.2.1.3 European Union
4.2.1.4 China
4.2.1.5 India
4.2.1.6 Japan
4.2.1.7 South Korea
4.2.1.8 Australia
4.2.1.9 Russia
4.2.1.10 Brazil
4.2.1.11 Mexico
4.2.1.12 Turkey
4.2.1.13 GCC Countries
4.2.1.14 Israel
4.2.2 Product Pipeline for New Vaccines
4.2.2.1 Product Pipeline for HIV
4.2.2.2 Product Pipeline for Zika Virus
4.2.2.3 Product Pipeline for Ebola Virus
4.2.2.4 Product Pipeline for COVID-19
5 Global Vaccine Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Technology
6.1 Conjugate Vaccines
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Inactivated and Subunit Vaccines
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Live Attenuated Vaccines
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Recombinant Vaccines
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Toxoid Vaccines
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Others
6.6.1 Market Trends
6.6.2 Market Forecast
7 Market Breakup by Patient Type
7.1 Paediatric
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Adult
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Indication
8.1 Bacterial Diseases
8.1.1 Market Trends
8.1.2 Major Types
8.1.2.1 Meningococcal Disease
8.1.2.1.1 Market Trends
8.1.2.1.2 Market Forecast
8.1.2.2 Pneumococcal Disease
8.1.2.2.1 Market Trends
8.1.2.2.2 Market Forecast
8.1.2.3 Diphtheria/Tetanus/Pertussis (DPT)
8.1.2.3.1 Market Trends
8.1.2.3.2 Market Forecast
8.1.2.4 Tuberculosis
8.1.2.4.1 Market Trends
8.1.2.4.2 Market Forecast
8.1.2.5 Haemophilus Influenzae (Hib)
8.1.2.5.1 Market Trends
8.1.2.5.2 Market Forecast
8.1.2.6 Typhoid
8.1.2.6.1 Market Trends
8.1.2.6.2 Market Forecast
8.1.2.7 Others
8.1.2.7.1 Market Trends
8.1.2.7.2 Market Forecast
8.1.3 Market Forecast
8.2 Viral Diseases
8.2.1 Market Trends
8.2.2 Major Types
8.2.2.1 Hepatitis
8.2.2.1.1 Market Trends
8.2.2.1.2 Market Forecast
8.2.2.2 Influenza
8.2.2.2.1 Market Trends
8.2.2.2.2 Market Forecast
8.2.2.3 Human Papillomavirus (HPV)
8.2.2.3.1 Market Trends
8.2.2.3.2 Market Forecast
8.2.2.4 Measles/Mumps/Rubella (MMR)
8.2.2.4.1 Market Trends
8.2.2.4.2 Market Forecast
8.2.2.5 Rotavirus
8.2.2.5.1 Market Trends
8.2.2.5.2 Market Forecast
8.2.2.6 Herpes Zoster
8.2.2.6.1 Market Trends
8.2.2.6.2 Market Forecast
8.2.2.7 Varicella
8.2.2.7.1 Market Trends
8.2.2.7.2 Market Forecast
8.2.2.8 Japanese Encephalitis
8.2.2.8.1 Market Trends
8.2.2.8.2 Market Forecast
8.2.2.9 Rubella
8.2.2.9.1 Market Trends
8.2.2.9.2 Market Forecast
8.2.2.10 Polio
8.2.2.10.1 Market Trends
8.2.2.10.2 Market Forecast
8.2.2.11 Rabies
8.2.2.11.1 Market Trends
8.2.2.11.2 Market Forecast
8.2.2.12 Dengue
8.2.2.12.1 Market Trends
8.2.2.12.2 Market Forecast
8.2.2.13 Others
8.2.2.13.1 Market Trends
8.2.2.13.2 Market Forecast
8.2.3 Market Forecast
9 Market Breakup by Route of Administration
9.1 Intramuscular and Subcutaneous Administration
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Oral Administration
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Product Type
10.1 Multivalent Vaccine
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Monovalent Vaccine
10.2.1 Market Trends
10.2.2 Market Forecast
11 Market Breakup by Treatment Type
11.1 Preventive Vaccine
11.1.1 Market Trends
11.1.2 Market Forecast
11.2 Therapeutic Vaccine
11.2.1 Market Trends
11.2.2 Market Forecast
12 Market Breakup by End User
12.1 Hospitals
12.1.1 Market Trends
12.1.2 Market Forecast
12.2 Clinics
12.2.1 Market Trends
12.2.2 Market Forecast
12.3 Vaccination Centres
12.3.1 Market Trends
12.3.2 Market Forecast
12.4 Academic and Research Institutes
12.4.1 Market Trends
12.4.2 Market Forecast
12.5 Others
12.5.1 Market Trends
12.5.2 Market Forecast
13 Market Breakup by Distribution Channel
13.1 Hospital Pharmacies
13.1.1 Market Trends
13.1.2 Market Forecast
13.2 Retail Pharmacies
13.2.1 Market Trends
13.2.2 Market Forecast
13.3 Institutional Sales
13.3.1 Market Trends
13.3.2 Market Forecast
13.4 Others
13.4.1 Market Trends
13.4.2 Market Forecast
14 Market Breakup by Region
14.1 North America
14.1.1 United States
14.1.1.1 Market Trends
14.1.1.2 Market Forecast
14.1.2 Canada
14.1.2.1 Market Trends
14.1.2.2 Market Forecast
14.2 Asia Pacific
14.2.1 China
14.2.1.1 Market Trends
14.2.1.2 Market Forecast
14.2.2 Japan
14.2.2.1 Market Trends
14.2.2.2 Market Forecast
14.2.3 India
14.2.3.1 Market Trends
14.2.3.2 Market Forecast
14.2.4 South Korea
14.2.4.1 Market Trends
14.2.4.2 Market Forecast
14.2.5 Australia
14.2.5.1 Market Trends
14.2.5.2 Market Forecast
14.2.6 Others
14.2.6.1 Market Trends
14.2.6.2 Market Forecast
14.3 Europe
14.3.1 Germany
14.3.1.1 Market Trends
14.3.1.2 Market Forecast
14.3.2 France
14.3.2.1 Market Trends
14.3.2.2 Market Forecast
14.3.3 United Kingdom
14.3.3.1 Market Trends
14.3.3.2 Market Forecast
14.3.4 Italy
14.3.4.1 Market Trends
14.3.4.2 Market Forecast
14.3.5 Spain
14.3.5.1 Market Trends
14.3.5.2 Market Forecast
14.3.6 Russia
14.3.6.1 Market Trends
14.3.6.2 Market Forecast
14.3.7 Others
14.3.7.1 Market Trends
14.3.7.2 Market Forecast
14.4 Latin America
14.4.1 Brazil
14.4.1.1 Market Trends
14.4.1.2 Market Forecast
14.4.2 Mexico
14.4.2.1 Market Trends
14.4.2.2 Market Forecast
14.4.3 Others
14.4.3.1 Market Trends
14.4.3.2 Market Forecast
14.5 Middle East and Africa
14.5.1 Turkey
14.5.1.1 Market Trends
14.5.1.2 Market Forecast
14.5.2 GCC Countries
14.5.2.1 Market Trends
14.5.2.2 Market Forecast
14.5.3 Israel
14.5.3.1 Market Trends
14.5.3.2 Market Forecast
14.5.4 Others
14.5.4.1 Market Trends
14.5.4.2 Market Forecast
15 SWOT Analysis
15.1 Overview
15.2 Strengths
15.3 Weaknesses
15.4 Opportunities
15.5 Threats
16 Value Chain Analysis
16.1 Exploratory Stage
16.2 Preclinical and Clinical Development
16.3 Regulatory Approval
16.4 Manufacturing
16.5 Marketing and Distribution
17 Porters Five Forces Analysis
17.1 Overview
17.2 Bargaining Power of Buyers
17.3 Bargaining Power of Suppliers
17.4 Degree of Competition
17.5 Threat of New Entrants
17.6 Threat of Substitutes
18 Price Analysis
19 Major Drivers and Challenges
20 Competitive Landscape
20.1 Market Structure
20.2 Key Players
20.3 Profiles of Key Players
20.3.1 Abbott Laboratories
20.3.1.1 Company Overview
20.3.1.2 Product Portfolio
20.3.1.3 Financials
20.3.1.4 SWOT Analysis
20.3.2 Astellas Pharma Inc.
20.3.2.1 Company Overview
20.3.2.2 Product Portfolio
20.3.2.3 Financials
20.3.2.4 SWOT Analysis
20.3.3 AstraZeneca Plc
20.3.3.1 Company Overview
20.3.3.2 Product Portfolio
20.3.3.3 Financials
20.3.3.4 SWOT Analysis
20.3.4 Bharat Biotech International
20.3.4.1 Company Overview
20.3.4.2 Product Portfolio
20.3.5 Bavarian Nordic A/S
20.3.5.1 Company Overview
20.3.5.2 Product Portfolio
20.3.5.3 Financials
20.3.6 CSL Limited
20.3.6.1 Company Overview
20.3.6.2 Product Portfolio
20.3.6.3 Financials
20.3.6.4 SWOT Analysis
20.3.7 Daiichi Sankyo Company Limited
20.3.7.1 Company Overview
20.3.7.2 Product Portfolio
20.3.8 Emergent BioSolutions Inc.
20.3.8.1 Company Overview
20.3.8.2 Product Portfolio
20.3.8.3 Financials
20.3.8.4 SWOT Analysis
20.3.9 GlaxoSmithKline Plc
20.3.9.1 Company Overview
20.3.9.2 Product Portfolio
20.3.9.3 Financials
20.3.9.4 SWOT Analysis
20.3.10 Inovio Pharmaceuticals Inc.
20.3.10.1 Company Overview
20.3.10.2 Product Portfolio
20.3.10.3 Financials
20.3.10.4 SWOT Analysis
20.3.11 Johnson & Johnson
20.3.11.1 Company Overview
20.3.11.2 Product Portfolio
20.3.11.3 Financials
20.3.11.4 SWOT Analysis
20.3.12 Merck & Co. Inc.
20.3.12.1 Company Overview
20.3.12.2 Product Portfolio
20.3.12.3 Financials
20.3.12.4 SWOT Analysis
20.3.13 Mitsubishi Tanabe Pharma Corporation (Mitsubishi Chemical Holdings Corporation)
20.3.13.1 Company Overview
20.3.13.2 Product Portfolio
20.3.13.3 Financials
20.3.13.4 SWOT Analysis
20.3.14 Novavax Inc.
20.3.14.1 Company Overview
20.3.14.2 Product Portfolio
20.3.14.3 Financials
20.3.14.4 SWOT Analysis
20.3.15 Panacea Biotec Ltd.
20.3.15.1 Company Overview
20.3.15.2 Product Portfolio
20.3.16 Pfizer Inc.
20.3.16.1 Company Overview
20.3.16.2 Product Portfolio
20.3.16.3 Financials
20.3.16.4 SWOT Analysis
20.3.17 Sanofi Pasteur SA (Sanofi SA)
20.3.17.1 Company Overview
20.3.17.2 Product Portfolio
20.3.17.3 Financials
20.3.17.4 SWOT Analysis
20.3.18 Serum Institute of India Pvt. Ltd.
20.3.18.1 Company Overview
20.3.18.2 Product Portfolio
20.3.19 Takeda Pharmaceutical Company Limited
20.3.19.1 Company Overview
20.3.19.2 Product Portfolio
20.3.19.3 Financials
20.3.19.4 SWOT Analysis
List of Figures
Figure 1: Global: Vaccine Market: Major Drivers and Challenges
Figure 2: Global: Vaccine Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Vaccine Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Vaccine Market: Breakup by Technology (in %), 2023
Figure 5: Global: Vaccine Market: Breakup by Patient Type (in %), 2023
Figure 6: Global: Vaccine Market: Breakup by Indication (in %), 2023
Figure 7: Global: Vaccine Market: Breakup by Route of Administration (in %), 2023
Figure 8: Global: Vaccine Market: Breakup by Product Type (in %), 2023
Figure 9: Global: Vaccine Market: Breakup by Treatment Type (in %), 2023
Figure 10: Global: Vaccine Market: Breakup by End User (in %), 2023
Figure 11: Global: Vaccine Market: Breakup by Distribution Channel (in %), 2023
Figure 12: Global: Vaccine Market: Breakup by Region (in %), 2023
Figure 13: Global: Vaccine (Conjugate Vaccines) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Vaccine (Conjugate Vaccines) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Vaccine (Inactivated and Subunit Vaccines) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Vaccine (Inactivated and Subunit Vaccines) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Vaccine (Live Attenuated Vaccines) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Vaccine (Live Attenuated Vaccines) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Vaccine (Recombinant Vaccines) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Vaccine (Recombinant Vaccines) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Vaccine (Toxoid Vaccines) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Vaccine (Toxoid Vaccines) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Vaccine (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Vaccine (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Vaccine (Paediatric) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Vaccine (Paediatric) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Vaccine (Adult) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Vaccine (Adult) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Vaccine (Bacterial Diseases) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Vaccine (Bacterial Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Vaccine (Meningococcal Disease) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Vaccine (Meningococcal Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Global: Vaccine (Pneumococcal Disease) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Global: Vaccine (Pneumococcal Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Global: Vaccine (Diphtheria/Tetanus/Pertussis-DPT) Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Global: Vaccine (Diphtheria/Tetanus/Pertussis-DPT) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: Global: Vaccine (Tuberculosis) Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: Global: Vaccine (Tuberculosis) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: Global: Vaccine (Haemophilus Influenzae-Hib) Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: Global: Vaccine (Haemophilus Influenzae-Hib) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Global: Vaccine (Typhoid) Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Global: Vaccine (Typhoid) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: Global: Vaccine (Other Bacterial Diseases) Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: Global: Vaccine (Other Bacterial Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: Global: Vaccine (Viral Diseases) Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: Global: Vaccine (Viral Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: Global: Vaccine (Hepatitis) Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: Global: Vaccine (Hepatitis) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: Global: Vaccine (Influenza) Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: Global: Vaccine (Influenza) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: Global: Vaccine (Human Papillomavirus-HPV) Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: Global: Vaccine (Human Papillomavirus-HPV) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: Global: Vaccine (Measles/Mumps/Rubella-MMR) Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: Global: Vaccine (Measles/Mumps/Rubella-MMR) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: Global: Vaccine (Rotavirus) Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: Global: Vaccine (Rotavirus) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: Global: Vaccine (Herpes Zoster) Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: Global: Vaccine (Herpes Zoster) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: Global: Vaccine (Varicella) Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: Global: Vaccine (Varicella) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Global: Vaccine (Japanese Encephalitis) Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Global: Vaccine (Japanese Encephalitis) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: Global: Vaccine (Rubella) Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: Global: Vaccine (Rubella) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: Global: Vaccine (Polio) Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: Global: Vaccine (Polio) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: Global: Vaccine (Rabies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: Global: Vaccine (Rabies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Global: Vaccine (Dengue) Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Global: Vaccine (Dengue) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Global: Vaccine (Other Viral Diseases) Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Global: Vaccine (Other Viral Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Global: Vaccine (Intramuscular and Subcutaneous Administration) Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Global: Vaccine (Intramuscular and Subcutaneous Administration) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Global: Vaccine (Oral Administration) Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Global: Vaccine (Oral Administration) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Global: Vaccine (Other Routes of Administration) Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Global: Vaccine (Other Routes of Administration) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Global: Vaccine (Multivalent Vaccine) Market: Sales Value (in Million US$), 2018 & 2023
Figure 80: Global: Vaccine (Multivalent Vaccine) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Global: Vaccine (Monovalent Vaccine) Market: Sales Value (in Million US$), 2018 & 2023
Figure 82: Global: Vaccine (Monovalent Vaccine) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 83: Global: Vaccine (Preventive Vaccine) Market: Sales Value (in Million US$), 2018 & 2023
Figure 84: Global: Vaccine (Preventive Vaccine) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 85: Global: Vaccine (Therapeutic Vaccine) Market: Sales Value (in Million US$), 2018 & 2023
Figure 86: Global: Vaccine (Therapeutic Vaccine) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 87: Global: Vaccine (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
Figure 88: Global: Vaccine (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 89: Global: Vaccine (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 90: Global: Vaccine (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 91: Global: Vaccine (Vaccination Centres) Market: Sales Value (in Million US$), 2018 & 2023
Figure 92: Global: Vaccine (Vaccination Centres) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 93: Global: Vaccine (Academic and Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 94: Global: Vaccine (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 95: Global: Vaccine (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
Figure 96: Global: Vaccine (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 97: Global: Vaccine (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 98: Global: Vaccine (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 99: Global: Vaccine (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 100: Global: Vaccine (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 101: Global: Vaccine (Institutional Sales) Market: Sales Value (in Million US$), 2018 & 2023
Figure 102: Global: Vaccine (Institutional Sales) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 103: Global: Vaccine (Other Distribution Channels) Market: Sales Value (in Million US$), 2018 & 2023
Figure 104: Global: Vaccine (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 105: North America: Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 106: North America: Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 107: United States: Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 108: United States: Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 109: Canada: Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 110: Canada: Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 111: Asia Pacific: Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 112: Asia Pacific: Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 113: China: Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 114: China: Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 115: Japan: Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 116: Japan: Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 117: India: Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 118: India: Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 119: South Korea: Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 120: South Korea: Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 121: Australia: Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 122: Australia: Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 123: Others: Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 124: Others: Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 125: Europe: Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 126: Europe: Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 127: Germany: Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 128: Germany: Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 129: France: Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 130: France: Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 131: United Kingdom: Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 132: United Kingdom: Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 133: Italy: Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 134: Italy: Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 135: Spain: Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 136: Spain: Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 137: Russia: Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 138: Russia: Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 139: Others: Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 140: Others: Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 141: Latin America: Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 142: Latin America: Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 143: Brazil: Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 144: Brazil: Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 145: Mexico: Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 146: Mexico: Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 147: Others: Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 148: Others: Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 149: Middle East and Africa: Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 150: Middle East and Africa: Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 151: Turkey: Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 152: Turkey: Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 153: GCC Countries: Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 154: GCC Countries: Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 155: Israel: Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 156: Israel: Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 157: Others: Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 158: Others: Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 159: Global: Vaccine Industry: SWOT Analysis
Figure 160: Global: Vaccine Industry: Value Chain Analysis
Figure 161: Global: Vaccine Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: Global: Vaccine Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Vaccine Market Forecast: Breakup by Technology (in Million US$), 2024-2032
Table 3: Global: Vaccine Market Forecast: Breakup by Patient Type (in Million US$), 2024-2032
Table 4: Global: Vaccine Market Forecast: Breakup by Indication (in Million US$), 2024-2032
Table 5: Global: Vaccine Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
Table 6: Global: Vaccine Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
Table 7: Global: Vaccine Market Forecast: Breakup by Treatment Type (in Million US$), 2024-2032
Table 8: Global: Vaccine Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 9: Global: Vaccine Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 10: Global: Vaccine Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 11: Global: Vaccine Market: Competitive Structure
Table 12: Global: Vaccine Market: Key Players
Purchase options
Benefits of Customization
Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-713-2163
Email: sales@imarcgroup.com
Client Testimonials
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
Read More
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
Read More
Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.
Read More.webp)
We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.
Read More
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
Read More
The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.
Read More
My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.
Read More
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
Read More.webp){kind=logo}
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.
Read More
IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.
Read More